https://www.selleckchem.com/pr....oducts/7-12-dimethyl
involving a larger cohort of patients might allow a more meaningful analysis of trends in the recurrence site with evolving radiotherapy techniques. Watering eyes is a common late adverse event associated with S-1 chemotherapy; however, the frequency and predictive factors are not known. This study included 304 consecutive gastric cancer patients treated with adjuvant S-1 monotherapy for 1year at Shizuoka Cancer Center. We retrospectively evaluated the frequency of watering eyes, and explored other nonhematol
Aimer
Commentaire
Partagez
